Surveillance and case investigation for monkeypox in the current context provides optimal clinical care but also isolates cases to prevent further transmission
What is Monkeypox?
Monkeypox is a rare sylvatic zoonosis caused by DNA virus, called monkeypox virus, belonging to the family Poxviridae.
Transmission occurs from person-to-person through close direct contact with lesions (vesicles) and mucous membranes, body fluids and even through respiratory droplets expelled into the air and fomites.
The incubation period can range from 5 - 21 days. The disease is often self limiting, and symptoms usually resolve spontaneously within 5 - 21 days after onset.
As of 23 May 2022, 67 confirmed cases had been reported in nine EU/EEA Member States and at least 42 suspected cases were still under investigation.
Our Monkeypox Virus Real Time PCR Detection method is designed for the qualitative identification of DNA from Monkeypox virus in serum, vesicle/cutaneous-skin fluid, fluid from wounds and swab wound from individuals suspected of Monkeypox virus infection by their healthcare provider
Any positive RT-PCR results will be further analysed by a national reference such as The Cyprus Institute of Genetics or State Hospital. Any suspicious result must be also reported to the authorities.